PANews reported on February 12th that, according to PRNewswire, AI quantitative trading firm Inference Research announced the completion of a $20 million seed fundingPANews reported on February 12th that, according to PRNewswire, AI quantitative trading firm Inference Research announced the completion of a $20 million seed funding
Inference Research has raised $20 million in seed funding, led by Avenir Group, founded by Li Lin.
PANews reported on February 12th that, according to PRNewswire, AI quantitative trading firm Inference Research announced the completion of a $20 million seed funding round, led by Avenir Group, founded by Li Lin. This round of funding will be used to expand its sovereign AI infrastructure and recruit top quantitative, engineering, and research talent.
Inference Research is an AI-powered quantitative trading firm that leverages the convergence of digital assets and traditional finance. The company combines its proprietary AI technology with institutional-grade trading discipline, and its operations span digital assets, traditional markets, and emerging sectors.
Market Opportunity
SEED Price(SEED)
$0.0004745
$0.0004745$0.0004745
USD
SEED (SEED) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Strategy Issues Preferred Stock to Steady Bitcoin Bet
Strategy is increasing its program of preferred stocks to buy more Bitcoins as it seeks to reduce the impact of market volatility. The company wants to continue
Share
Thenewscrypto2026/02/12 17:55
Vivex Announces New Peer-Reviewed Publication Demonstrating Long-Term Fusion Outcomes with VIA Form+™ in Lumbar Interbody Fusion
MIAMI, Feb. 12, 2026 /PRNewswire/ — Vivex Biologics, Inc., a leading medical technology company developing and delivering innovative allografts for musculoskeletal
Share
AI Journal2026/02/12 21:32
ZeroHash Ignites Crypto Payments Boom With USDC on Monad as Institutions Rush In
ZeroHash USDC Integration Signals Next Phase for Crypto Payments and Institutional Adoption
ZeroHash, a digital asset infrastructure provider recently valued
Share
Hokanews2026/02/12 21:17